Navigation Links
IntriMed Technologies Launched to Address Challenges Faced by Medical Device Manufacturers
Date:9/14/2010

OXNARD, Calif., Sept. 14 /PRNewswire/ -- The launch of IntriMed Technologies and the opening of IntriMed's first state-of-the-industry Innovation Center in Oxnard, Calif. were announced today by IntriPlex Technologies, a global leader in the design and manufacture of ultra-precise components for the data storage and healthcare industries. Founded on a 23 year heritage of engineering innovation, IntriMed (www.intrimed.com) focuses exclusively on delivering outsourcing solutions to the medical device manufacturing industry, and delivers on three value pillars - ongoing innovation, deep collaboration, and engineering and operational excellence.

As with any industry, the medical device industry continues to evolve and adapt to ever-changing market dynamics. Faced with healthcare reform, a new medical device tax, rapid technology advancement and more stringent U.S. Food and Drug Administration (FDA) oversight, original equipment manufacturers (OEMs) are increasingly looking towards strategic, long-term outsourcing partnerships as a means to temper these changes and achieve their revenue, cost and competitive objectives more rapidly.

Leveraging design innovation and manufacturing excellence that has resulted in 44 product and process patents and over 9 billion precision components, IntriMed is well-positioned to help medical device OEMs address these challenges. IntriMed provides deep engineering expertise to support product development from initial concept through volume production and assembly, and taps into OEM objectives to create highly-specialized design and process solutions that result in reduced costs, faster times to market, decreased failure rates and competitive differentiation.

IntriMed's new Innovation Center will support the company's full range of services, including product design and development, rapid prototyping, advanced tooling, precision manufacturing, secondary processing and cleaning, custom metrology and final assembly.

"Medical device manufacturers are adjusting to a 'new normal' of doing more with less," said Larry J. Czapla, IntriMed's president, "but for us this is pretty familiar ground. We've managed to help manufacturers in the disk drive industry save millions of dollars and stay ahead of a huge technology curve by laying the foundation for manufacturing success early on. From the outset, we work closely with the development team to create a tailored approach to design and manufacturing, and to help them achieve new levels of quality, technology and cost-effectiveness."

IntriMed's team of executives holds extensive leadership experience at the world's top medical device companies. The executive team includes Larry J. Czapla, President; Lawney Falloon, Chief Executive Officer; Damon Brink, Ph.D., Chief Technology Officer and Vice President, Engineering; Larry Ellis, Chief Financial Officer; Andrew Lux, Ph.D., Senior Vice President, Operations and Manufacturing; and Howard R. Baker, Vice President, Business Development and Commercial Operations.

For more information about IntriMed Technologies, please visit www.intrimed.com.

About IntriMed TechnologiesIntriMed Technologies designs, manufactures and assembles ultra-precision mechanical components critical to medical device functionality. We draw on more than 23 years of experience helping manufacturers do more with less – providing innovative product and process design, meticulous quality systems, and highly scalable, fully compliant manufacturing capabilities. The result is truly differentiated medical devices produced more cost effectively.

Think "embedded engineering": leveraging our considerable resources so our customers can better focus theirs. To learn more, visit intrimed.com.Media Contact: Priya DuaPorter Novelli Life SciencesPriya.Dua@porternovelli.com323-762-2407
'/>"/>

SOURCE IntriMed Technologies
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results
2. RainDance Technologies Appoints Olex Vice President, System Development
3. Palatin Technologies, Inc. Reports Positive Results of Phase 2a Clinical Study with PL-3994 for the Treatment of Heart Failure
4. Reliant Technologies Announces Canadian Launch of Fraxel re:pair(R) Laser: A New Class of Treatment Therapy for CO2 Laser Skin Resurfacing
5. RF Technologies(R) Installs Safe Place(R) Solution for Pediatric and Infant Security at ProHealth Cares Waukesha Memorial Hospital
6. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
7. Cryo-Cell International and EndGenitor Technologies Announce Research Collaboration
8. Anthill Technologies Announces Agreement With Zafgen
9. Neptune Technologies Reports Record Fiscal 2008 Fourth Quarter and Year End Results
10. BioSpecifics Technologies Corp. Buys Down Royalties for Peyronies Disease
11. Neptune Technologies successfully completes up to $8.5 million debt financing with Desjardins Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , ... June 27, 2016 , ... Parallel 6 ... trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module which ... with the physician and clinical trial team. , Using the CONSULT module, patients and ...
(Date:6/27/2016)... Ginkgo Bioworks , a leading organism design company ... as one of the World Economic Forum,s Technology ... companies. Ginkgo Bioworks is engineering biology to manufacture ... the nutrition, health and consumer goods sectors. The ... Fortune 500 companies to design microbes for their ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle ... people with peritoneal or pleural mesothelioma. Their findings are the subject of a new ... , Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
Breaking Biology Technology:
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
(Date:4/15/2016)... , April 15, 2016 ... "Global Gait Biometrics Market 2016-2020,"  report to their ... ) , ,The global gait biometrics market ... 13.98% during the period 2016-2020. Gait ... which can be used to compute factors that ...
Breaking Biology News(10 mins):